Patents by Inventor Maria Victoria Silva Elipe

Maria Victoria Silva Elipe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11702380
    Abstract: Provided herein are synthetic methods for the preparation of intermediates that are utilized in the synthesis of omecamtiv mecarbil dihydrochloride.
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: July 18, 2023
    Assignee: Amgen Inc.
    Inventors: Sebastien Caille, James Murray, Kyle Quasdorf, Hannah Nguyen, Maria Victoria Silva Elipe, Ari Elizabeth Ericson
  • Publication number: 20220298099
    Abstract: Provided herein are synthetic methods for the preparation of intermediates that are utilized in the synthesis of omecamtiv mecarbil dihydrochloride.
    Type: Application
    Filed: March 9, 2022
    Publication date: September 22, 2022
    Inventors: Sebastien CAILLE, James MURRAY, Kyle QUASDORF, Hannah NGUYEN, Maria Victoria SILVA ELIPE, Ari Elizabeth ERICSON
  • Publication number: 20020040030
    Abstract: The present invention relates to novel compounds formed by metabolic conversion of compounds of the structural formula depicted below (R═H or Me), pharmaceutical compositions containing such compounds, and their use as &agr;v&bgr;3 integrin receptor antagonists. The compounds of the present invention are useful for inhibiting bone resorption, restenosis, angiogenesis, diabetic retinopathy, macular degeneration, inflammatory arthritis, cancer, and metastatic tumor growth. They are particularly useful for inhibiting bone resorption and for the treatment and prevention of osteoporosis.
    Type: Application
    Filed: September 14, 2001
    Publication date: April 4, 2002
    Inventors: Paul J. Coleman, Donghui Cui, Mark E. Duggan, John H. Hutchinson, Thomayant Prueksaritanont, Maria Victoria Silva Elipe, Xiaojun Fang